FDA Warning Letter — Cooper Institute For Advanced Reproductive Medicine
The FDA took a Warning Letter action against Cooper Institute For Advanced Reproductive Medicine on Nov 15, 2021 (Houston, TX). The action was issued by CBER and concerns biologics products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Cooper Institute For Advanced Reproductive Medicine
- Date
- Nov 15, 2021
- Fiscal Year
- 2022
- Product Type
- Biologics
- Center
- CBER
- Location
- Houston, TX (United States)